Pharmacodynamic evaluation of the XOR inhibitor WN1703 in a model of chronic hyperuricemia in rats induced by yeast extract combined with potassium oxonate-Reference-Cited by-同舟云学术

Pharmacodynamic evaluation of the XOR inhibitor WN1703 in a model of chronic hyperuricemia in rats induced by yeast extract combined with potassium oxonate

Published:2022 Issue: Volume:3 Page:100098
ISSN:2590-2571
Container-title:Current Research in Pharmacology and Drug Discovery
language:en
Short-container-title:Current Research in Pharmacology and Drug Discovery

Author:

Li Yuanyuan,Zhu Xinying,Liu Fuyao,Peng Wen,Zhang Lei,Li Jing

Publisher

Elsevier BV

Subject

Animal Science and Zoology,Ecology, Evolution, Behavior and Systematics

Reference30 articles.

1. Hyperuricemia and gout; the role of diet;Álvarez-Lario;Nutr. Hosp.,2014

2. Urate-induced immune programming: consequences for gouty arthritis and hyperuricemia;Cabau;Immunol. Rev.,2020

3. Preventive effects of fucoidan and fucoxanthin on hyperuricemic rats induced by potassium oxonate;Chau;Mar. Drugs,2019

4. Hypersensitivity and cardiovascular risks related to allopurinol and febuxostat therapy in Asians: a population-based cohort study and meta-analysis;Chen;Clin. Pharmacol. Ther.,2019

5. Curcumin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation in mice;Chen;Biomed. Pharmacother.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. WN1703 alleviates gout symptoms via inflammatory signaling pathways in an acute gout rat model;Pharmaceutical Science Advances;2024-12

2. Study on the mechanism of Orthosiphon aristatus (Blume) Miq. in the treatment of hyperuricemia by microbiome combined with metabonomics;Journal of Ethnopharmacology;2023-12

3. Lactic acid bacteria with anti-hyperuricemia ability: Screening in vitro and evaluating in mice;Food Bioscience;2023-04